Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

NCT00499603 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: 5-Fluorouracil
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: RAD001

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]